Literature DB >> 9326671

Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release.

C J Small1, D G Morgan, K Meeran, M M Heath, I Gunn, C M Edwards, J Gardiner, G M Taylor, J D Hurley, M Rossi, A P Goldstone, D O'Shea, D M Smith, M A Ghatei, S R Bloom.   

Abstract

Hypothalamic neuropeptide Y (NPY) is thought to be important in the regulation of feeding and also in the release of Adrenocorticotrophic hormone (ACTH). Intracerebroventricular administration of NPY to male rats significantly increased plasma ACTH 10 min after injection and stimulated 2-h food intake. A series of analogues of NPY that have a greatly reduced affinity for the Y1 [human pancreatic polypeptide (human PP), NPY(3-36)], the Y2 ([Pro34]NPY, human PP), the Y3 (peptide YY), and the Y6 (human PP) receptor, all markedly stimulated ACTH release. Rat PP, which binds with high affinity to the Y4 receptor, was unable to stimulate ACTH release. A novel analogue fragment [Pro34]NPY(13-36) was synthesized as a ligand with low Y1 and Y2 receptor affinity. Interestingly, neither [Pro34]NPY(13-36) nor the selective Y5 receptor agonist [D-Trp32]NPY stimulated food intake, whereas both significantly increased plasma ACTH. Thus the hypothalamic NPY receptor mediating increases in plasma ACTH has a fragment activation profile unlike the Y1-Y4 or Y6 receptors and appears distinct from the NPY receptor controlling food intake.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9326671      PMCID: PMC23590          DOI: 10.1073/pnas.94.21.11686

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

Review 1.  Apparent affinity and potency of BIBP3226, a non-peptide neuropeptide Y receptor antagonist, on purported neuropeptide Y Y1, Y2 and Y3 receptors.

Authors:  D Jacques; A Cadieux; Y Dumont; R Quirion
Journal:  Eur J Pharmacol       Date:  1995-05-04       Impact factor: 4.432

2.  Brain neuropeptide Y in the control of adrenocorticotropic hormone secretion in the dog.

Authors:  A Inui; T Inoue; M Nakajima; M Okita; N Sakatani; Y Okimura; K Chihara; S Baba
Journal:  Brain Res       Date:  1990-03-05       Impact factor: 3.252

Review 3.  Neuropeptide Y effector systems: perspectives for drug development.

Authors:  L Grundemar; R Håkanson
Journal:  Trends Pharmacol Sci       Date:  1994-05       Impact factor: 14.819

4.  Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor.

Authors:  P M Rose; P Fernandes; J S Lynch; S T Frazier; S M Fisher; K Kodukula; B Kienzle; R Seethala
Journal:  J Biol Chem       Date:  1995-09-29       Impact factor: 5.157

5.  Activation of neuropeptide Y1 and neuropeptide Y2 receptors by substituted and truncated neuropeptide Y analogs: identification of signal epitopes.

Authors:  L Grundemar; J L Krstenansky; R Håkanson
Journal:  Eur J Pharmacol       Date:  1993-03-02       Impact factor: 4.432

6.  Neuropeptide Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus.

Authors:  T Suda; F Tozawa; I Iwai; Y Sato; T Sumitomo; Y Nakano; M Yamada; H Demura
Journal:  Brain Res Mol Brain Res       Date:  1993-06

7.  Peptide YY derivatives as selective neuropeptide Y/peptide YY Y1 and Y2 agonists devoided of activity for the Y3 receptor sub-type.

Authors:  Y Dumont; A Cadieux; L H Pheng; A Fournier; S St-Pierre; R Quirion
Journal:  Brain Res Mol Brain Res       Date:  1994-10

8.  Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats.

Authors:  C Catzeflis; D D Pierroz; F Rohner-Jeanrenaud; J E Rivier; P C Sizonenko; M L Aubert
Journal:  Endocrinology       Date:  1993-01       Impact factor: 4.736

9.  [D-TRP32]neuropeptide Y: a competitive antagonist of NPY in rat hypothalamus.

Authors:  A Balasubramaniam; S Sheriff; M E Johnson; M Prabhakaran; Y Huang; J E Fischer; W T Chance
Journal:  J Med Chem       Date:  1994-03-18       Impact factor: 7.446

10.  Superior cervical ganglionectomy suppresses circadian corticotropic rhythms in male rats in the short term (5 days) and long term (10 days).

Authors:  P Siaud; M Mekaouche; D Maurel; L Givalois; G Ixart
Journal:  Brain Res       Date:  1994-08-01       Impact factor: 3.252

View more
  8 in total

1.  NPY receptors as potential targets for anti-obesity drug development.

Authors:  Ernie Yulyaningsih; Lei Zhang; Herbert Herzog; Amanda Sainsbury
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

Review 2.  Neuropeptide Y and posttraumatic stress disorder.

Authors:  R Sah; T D Geracioti
Journal:  Mol Psychiatry       Date:  2012-07-17       Impact factor: 15.992

3.  The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder.

Authors:  Hagit Cohen; Tianmin Liu; Nitsan Kozlovsky; Zeev Kaplan; Joseph Zohar; Aleksander A Mathé
Journal:  Neuropsychopharmacology       Date:  2011-10-05       Impact factor: 7.853

4.  Urocortin I inhibits the effects of ghrelin and neuropeptide Y on feeding and energy substrate utilization.

Authors:  Paul J Currie; Christine D Coiro; Raya Duenas; Janet L Guss; Aaisha Mirza; Neta Tal
Journal:  Brain Res       Date:  2011-04-18       Impact factor: 3.252

5.  Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain.

Authors:  Y Dumont; A Fournier; R Quirion
Journal:  J Neurosci       Date:  1998-08-01       Impact factor: 6.167

6.  Adaptogens stimulate neuropeptide y and hsp72 expression and release in neuroglia cells.

Authors:  Alexander Panossian; Georg Wikman; Punit Kaur; Alexzander Asea
Journal:  Front Neurosci       Date:  2012-02-01       Impact factor: 4.677

7.  Central NPY-Y5 sub-receptor partially functions as a mediator of NPY-induced hypothermia and affords thermotolerance in heat-exposed fasted chicks.

Authors:  Hatem M Eltahan; Mohammad A Bahry; Hui Yang; Guofeng Han; Linh T N Nguyen; Hiromi Ikeda; Mohamed N Ali; Khairy A Amber; Mitsuhiro Furuse; Vishwajit S Chowdhury
Journal:  Physiol Rep       Date:  2017-12

8.  Forebrain overexpression of type 1 adenylyl cyclase promotes molecular stability and behavioral resilience to physical stress.

Authors:  Miyoung Yang; Qi Ding; Ming Zhang; Changjong Moon; Hongbing Wang
Journal:  Neurobiol Stress       Date:  2020-06-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.